スキャフォールド技術の世界市場2020-2027:種類別(ヒドロゲル、高分子スキャフォールド)、用途別、疾患種類別、エンドユーザー別、地域別

Table of Contents

Chapter 1 Scaffold Technology Market: Methodology and Scope
1.1 Information Procurement
1.1.1 Purchased database
1.1.2 GVR’s internal database
1.1.3 Secondary sources
1.1.4 Third party perspective
1.1.5 Primary research
1.2 Data Analysis
1.3 Market Formulation & Validation
1.4 Region Wise Market Calculation & Scope
1.4.1 Market scope: by application
1.4.2 Region wise market: Base estimates
1.4.3 Global market: CAGR calculation
1.4.4 Region based segment share calculation
Chapter 2 Scaffold Technology Market: Executive Summary
2.1 Market Summary, 2019
Chapter 3 Scaffold Technology Market: Market Variables, Trends, and Scope
3.1 Scaffold technology Market: Segment Outlook, 2016 – 2027
3.1.1 Market driver analysis
3.1.1.1 Increasing demand for 3D cellular models in translational research
3.1.1.2 Increasing demand for body reconstruction procedures and tissue engineering
3.1.1.3 Advancements in scaffold technology
3.1.2 Market restraint analysis
3.1.2.1 Introduction of scaffold-free technology for 3D cell culture
3.1.2.2 Lack of consistency in generated results
3.2 Penetration & Growth Prospect Mapping for Type, 2019
3.3 Scaffold Technology Market-SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Scaffold Technology Market: Type Estimates and Trend Analysis
4.1 Scaffold Technology Market: Type Movement Analysis, 2019 & 2027
4.2 Hydrogels
4.2.1 Scaffold technology market for hydrogels, 2016 – 2027 (USD Million)
4.2.2 Hydrogels, by application
4.2.2.1 Wound healing
4.2.3 Hydrogels market for wound healing, 2016 – 2027 (USD Million)
4.2.3.1 3D bioprinting
4.2.4 Hydrogels market for 3D bioprinting, 2016 – 2027 (USD Million)
4.2.4.1 Immunomodulation
4.2.5 Hydrogels market for immunomodulation, 2016 – 2027 (USD Million)
4.3 Polymeric Scaffolds
4.3.1 Scaffold technology market for polymeric scaffolds, 2016 – 2027 (USD Million)
4.4 Micropatterned Surface Microplates
4.4.1 Scaffold technology market for micropatterned surface microplates, 2016 – 2027 (USD Million)
4.5 Nanofiber-Based Scaffolds
4.5.1 Scaffold technology market for nanofiber-based scaffolds, 2016 – 2027 (USD Million)
Chapter 5 Scaffold Technology Market: Application Business Analysis
5.1 Scaffold Technology Market: Application Movement Analysis, 2019 & 2027
5.2 Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering
5.2.1 Cell encapsulations for regenerative medicine
5.2.2 Scaffold technology market for stem cell therapy, regenerative medicine, & tissue engineering, 2016 – 2027 (USD Million)
5.3 Drug Discovery
5.3.1 Scaffold technology market for drug discovery, 2016 – 2027 (USD Million)
5.4 Others
5.4.1 Scaffold technology market for others, 2016 – 2027 (USD Million)
Chapter 6 Scaffold Technology Market: Disease Type Estimates and Trend Analysis
6.1 Scaffold Technology Market: Disease Type Movement Analysis, 2019 & 2027
6.2 Orthopedics, Musculoskeletal, & Spine
6.2.1 Scaffold technology market for orthopedics, musculoskeletal, & spine, 2016 – 2027 (USD Million)
6.3 Cancer
6.3.1 Analysis of Extracellular Matrix (ECM) scaffolds and nanotechnology-based strategies for cancer diagnosis and prognosis
6.3.2 Scaffold technology market for cancer, 2016 – 2027 (USD Million)
6.4 Skin & Integumentary
6.4.1 Scaffold technology market for skin & integumentary, 2016 – 2027 (USD Million)
6.5 Dental
6.5.1 Strategies for developing new smart tissue engineering scaffolds for dentine‐pulp complex regeneration
6.5.2 Scaffold technology market for dental, 2016 – 2027 (USD Million)
6.6 Cardiology & Vascular
6.6.1 Scaffold technology market for cardiology & vascular, 2016 – 2027 (USD Million)
6.7 Neurology
6.7.1 Scaffold technology market for neurology, 2016 – 2027 (USD Million)
6.8 Urology
6.8.1 Scaffold technology market for urology, 2016 – 2027 (USD Million)
6.9 Gastrointestinal Disorders (GI) & Gynecology
6.9.1 Scaffold technology market for GI & gynecology, 2016 – 2027 (USD Million)
6.10 Others
6.10.1 Scaffold technology market for other disease types, 2016 – 2027 (USD Million)
Chapter 7 Scaffold Technology Market: End-use Estimates and Trend Analysis
7.1 Scaffold Technology Market: End-use Movement Analysis, 2019 & 2027
7.2 Biotechnology and Pharmaceutical Organizations
7.2.1 Scaffold technology market for biotechnology and pharmaceutical organizations, 2016 – 2027 (USD Million)
7.3 Research Laboratories and Institutes
7.3.1 Scaffold technology market for research laboratories and institutes, 2016 – 2027 (USD Million)
7.4 Hospitals and Diagnostic Centers
7.4.1 Scaffold technology market for hospitals and diagnostic centers, 2016 – 2027 (USD Million)
7.5 Others
7.5.1 Scaffold technology market for others, 2016 – 2027 (USD Million)
Chapter 8 Scaffold Technology Market: Region Business Analysis
8.1 Scaffold Technology Market: Regional Movement Analysis, 2019 & 2027
8.2 North America
8.2.1 North America scaffold technology market estimates and forecast, 2016 – 2027 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. scaffold technology market estimates and forecast, by type, 2016 – 2027 (USD Million)
8.2.2.2 U.S. scaffold technology market estimates and forecast, by application, 2016 – 2027 (USD Million)
8.2.2.3 U.S. scaffold technology market estimates and forecast, by disease type, 2016 – 2027 (USD Million)
8.2.2.4 U.S. scaffold technology market estimates and forecast, by end use, 2016 – 2027 (USD Million)
8.2.3 Canada
8.2.3.1 Canada scaffold technology market estimates and forecast, by type, 2016 – 2027 (USD Million)
8.2.3.2 Canada scaffold technology market estimates and forecast, by application, 2016 – 2027 (USD Million)
8.2.3.3 Canada scaffold technology market estimates and forecast, by disease type, 2016 – 2027 (USD Million)
8.2.3.4 Canada scaffold technology market estimates and forecast, by end use, 2016 – 2027 (USD Million)
8.3 Europe
8.3.1 Europe scaffold technology market estimates and forecast, 2016 – 2027 (USD Million)
8.3.2 Germany
8.3.2.1 Germany scaffold technology market estimates and forecast, by type, 2016 – 2027 (USD Million)
8.3.2.2 Germany scaffold technology market estimates and forecast, by application, 2016 – 2027 (USD Million)
8.3.2.3 Germany scaffold technology market estimates and forecast, by disease type, 2016 – 2027 (USD Million)
8.3.2.4 Germany scaffold technology market estimates and forecast, by end use, 2016 – 2027 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. scaffold technology market estimates and forecast, by type, 2016 – 2027 (USD Million)
8.3.3.2 U.K. scaffold technology market estimates and forecast, by application, 2016 – 2027 (USD Million)
8.3.3.3 U.K. scaffold technology market estimates and forecast, by disease type, 2016 – 2027 (USD Million)
8.3.3.4 U.K. scaffold technology market estimates and forecast, by end use, 2016 – 2027 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific scaffold technology market estimates and forecast, 2016 – 2027 (USD Million)
8.4.2 Japan
8.4.2.1 Japan scaffold technology market estimates and forecast, by type, 2016 – 2027 (USD Million)
8.4.2.2 Japan scaffold technology market estimates and forecast, by application, 2016 – 2027 (USD Million)
8.4.2.3 Japan scaffold technology market estimates and forecast, by disease type, 2016 – 2027 (USD Million)
8.4.2.4 Japan scaffold technology market estimates and forecast, by end use, 2016 – 2027 (USD Million)
8.4.3 China
8.4.3.1 China scaffold technology market estimates and forecast, by type, 2016 – 2027 (USD Million)
8.4.3.2 China scaffold technology market estimates and forecast, by application, 2016 – 2027 (USD Million)
8.4.3.3 China scaffold technology market estimates and forecast, by disease type, 2016 – 2027 (USD Million)
8.4.3.4 China scaffold technology market estimates and forecast, by end use, 2016 – 2027 (USD Million)
8.5 Latin America
8.5.1 Latin America scaffold technology market estimates and forecast, 2016 – 2027 (USD Million)
8.5.2 Brazil
8.5.3.1 Brazil scaffold technology market estimates and forecast, by type, 2016 – 2027 (USD Million)
8.5.3.2 Brazil scaffold technology market estimates and forecast, by application, 2016 – 2027 (USD Million)
8.5.3.3 Brazil scaffold technology market estimates and forecast, by disease type, 2016 – 2027 (USD Million)
8.5.3.4 Brazil scaffold technology market estimates and forecast, by end use, 2016 – 2027 (USD Million)
8.6 Middle East and Africa (MEA)
8.6.1 MEA scaffold technology market estimates and forecast, 2016 – 2027 (USD Million)
8.6.2 South Africa
8.6.3.1 South Africa scaffold technology market estimates and forecast, by type, 2016 – 2027 (USD Million)
8.6.3.2 South Africa scaffold technology market estimates and forecast, by application, 2016 – 2027 (USD Million)
8.6.3.3 South Africa scaffold technology market estimates and forecast, by disease type, 2016 – 2027 (USD Million)
8.6.3.4 South Africa scaffold technology market estimates and forecast, by end use, 2016 – 2027 (USD Million)
Chapter 9 Scaffold Technology Market: Company Profile
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Merck KGaA
9.3.1.1 Company Overview
9.3.1.2 Sigma-Aldrich, Inc.
9.3.1.2.1 Company Overview
9.3.1.3 Merck Millipore
9.3.1.3.1 Company Overview
9.3.1.4 Financial Performance
9.3.1.5 Product Benchmarking
9.3.1.6 Strategic Initiatives
9.3.2 Thermo Fisher Scientific, Inc.
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 BD (Becton, Dickinson and Company)
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product Benchmarking
9.3.4 3D Biotek LLC
9.3.4.1 Company Overview
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 Molecular Matrix, Inc.
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 REPROCELL, Inc.
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 Xanofi
9.3.7.1 Company Overview
9.3.7.2 Product Benchmarking
9.3.7.3 Strategic Initiatives
9.3.8 Tecan Trading AG
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 Matricel GmbH
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 Pelobiotech
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.11 Corning Incorporated
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
9.3.12 Akron Biotech
9.3.12.1 Company Overview
9.3.12.2 Financial Performance
9.3.12.3 Product Benchmarking
9.3.12.4 Strategic Initiatives
9.3.13 4titude
9.3.13.1 Company Overview
9.3.13.2 Financial Performance
9.3.13.3 Product Benchmarking
9.3.14 3D Biomatrix
9.3.14.1 Company Overview
9.3.14.2 Product Benchmarking
9.3.15 Nanofiber Solutions
9.3.15.1 Company Overview
9.3.15.2 Financial Performance
9.3.15.3 Product Benchmarking
9.3.15.4 Strategic Initiatives
9.3.16 NuVasive, Inc.
9.3.16.1 Company Overview
9.3.16.2 Financial Performance
9.3.16.3 Product Benchmarking
9.3.16.4 Strategic Initiatives
9.3.17 Avacta Life Sciences Limited
9.3.17.1 Company Overview
9.3.17.2 Financial Performance
9.3.17.3 Product Benchmarking
9.3.17.4 Strategic Initiatives
9.3.18 Medtronic
9.3.18.1 Company Overview
9.3.18.2 Financial Performance
9.3.18.3 Product Benchmarking
9.3.18.4 Strategic Initiatives
9.3.19 Allergan
9.3.19.1 Company Overview
9.3.19.2 LifeCell Corporation
9.3.19.2.1 Company Overview
9.3.19.3 Financial Performance
9.3.19.4 Product Benchmarking
9.3.19.5 Strategic Initiatives
9.3.20 Vericel Corporation
9.3.20.1 Company Overview
9.3.20.2 Financial Performance
9.3.20.3 Product Benchmarking
9.3.20.4 Strategic Initiatives

グローバル市場調査会社